CERN-MEDICIS (Medical Isotopes Collected from ISOLDE): A New Facility
Source abstract
Abstract
About 50% of the 1.4 GeV CERN (European Organization for Nuclear Research, www.cern.ch) protons are sent onto targets to produce radioactive beams by online mass separation at the Isotope Separator Online Device (ISOLDE) facility, for a wide range of studies in fundamental and applied physics. CERN-MEDICIS is a spin-off dedicated to R&D in life sciences and medical applications. It is located in an extension of the Class A building presently under construction. It will comprise laboratories to receive the irradiated targets from a new station located at the dump position behind the ISOLDE production targets. An increasing range of innovative isotopes will thus progressively become accessible from the start-up of the facility in 2015 onward; for fundamental studies in cancer research, for new imaging and therapy protocols in cell and animal models and for pre-clinical trials, possibly extended to specific early phase clinical studies up to Phase I trials. Five hundred megabecquerel isotope batches purified by electromagnetic mass separation combined with chemical methods will be collected on a weekly basis. A possible future upgrade with gigabecquerel pharmaceutical-grade i.e., current good manufacturing practices (cGMP) batch production capabilities is finally presented.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Boron Compounds in Chemistry · Radiopharmaceutical Chemistry and Applications · Chemical Reactions and Isotopes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
CERN, 23 Geneva, 1211-Geneva, Switzerland
Universitaires de Genève (HUG), Rue Gabrielle-Perret-Gentil 4, 1205-Geneva, Switzerland
References (37)
Show source-provided references
1. Stora, T., Da Visitacao, S.F., Mathot, S., and Bowen, P. (2009). Nanostructured Target for Isotope Production. (20110235766 A1), U.S. Patent.
2. Mendonca, T.M., Hodak, R., Ghetta, V., Allibert, M., Heuer, D., Noah, E., Cimmino, S., Delonca, M., Gottberg, A., and Kronberger, M. (2014). Production and release of ISOL beams from molten fluoride salt targets. Nucl. Instrum. Methods Phys. Res. Sect. B, submitted for publication.10.1016/j.nimb.2014.03.003 ↗
3. The FLUKA code: Description and benchmarking10.1063/1.2720455 ↗
4. Ferrari, A., Sala, P.R., Fassò, A., and Ranft, J. (2005). FLUKA: A Multi-Particle Transport Code, CERN.10.2172/877507 ↗
5. Access to the Yield information. Available online:https://oraweb.cern.ch/pls/isolde/query_tgt.
6. Sergey Vaintraub, Pierre Delahaye, Hanna Franberg-Delahaye, Marie-Genevieve Saint-Laurent and Gerard Lhersonneau. A high intensity 6He beam for the β-beam neutrino oscillation facility10.1209/0295-5075/98/32001 ↗
7. An automated module for the separation and purification of cyclotron-produced 99mTcO410.1016/j.nucmedbio.2011.10.006 ↗
8. Radioactive ion beams for biomedical research and nuclear medical application10.1023/A:1012670018533 ↗
9. Spallation-produced thulium-167 for medical applications
10. A new type of 81Rb-81mKr generator for medical use10.1016/0020-708X(84)90015-2 ↗
11. Beyer, G.J., and Bergmann, R. (November, January 30). Workshop on Endoradionuclide Therapy, Dresden, Germany.
12. The influence of EDTMP-concentration on the biodistribution of radio-lanthanides and 225-Ac in tumor-bearing mice10.1016/S0969-8051(97)80001-7 ↗
13. Proposal to the ISOLDE committee, CERN/ISC-4/P42 (ISOLDE experiment ISC330). Available online:https://cds.cern.ch/record/5299?ln=en.
14. Proposal to the ISOLDE committee, CERN/ISC93-14/ISC/P48 (ISOLDE experiment ISC331). Available online:https://cds.cern.ch/record/5298?ln=en.
15. Addendum to the proposal to the ISOLDE committee, CERN/ISC93-14/ISC/P48. Available online:http://cds.cern.ch/record/297279/.
16. Addendum 1 to ISOLDE experiments ISC330 and ISC331 from 4 May 1994. Available online:https://cds.cern.ch/record/294853/files/SC00000194.pdf.
17. A novel derivative of the chelon desferrioxamine for site specific conjugation to antibodies10.1002/ijc.2910430637 ↗
18. Biokinetics of monoclonal antibodies labeled with radio-lanthanides and 225-Ac in xenografted nude mice: Preliminary results
19. Comparison of the biokinetics of octreotide labeled with radio-lanthanides and 111In in tumor bearing rats
20. Is Tb-152 suitable to monitor tissue doses in alpha therapy with Tb-149 using PET?
21. Targeted alpha therapy in vivo: Direct evidence for single cancer cell kill using 149Tb-rituximab10.1007/s00259-003-1413-9 ↗
22. Proposal to the ISOLDE committe CERN/97-14/ISC/P-90 (ISOLDE experiment IS363). Available online:https://cds.cern.ch/record/491305?ln=en.
23. Addendum 1 to IS363 dated 31 January 2000. Available online:https://cds.cern.ch/record/430342?ln=en.
24. Beyer, G.J. (2005, January 10–12). Medical application of Radioactive ion beams. Presented at NuPEC, CERN, Geneva Switzerland.
25. A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β-Radionuclide Therapy: An in vivo proof-of-concept study with a new receptor-targeted folate derivative10.2967/jnumed.112.107540 ↗
26. Buchegger, F., Tourwe, D., Kosinski, M., Viertl, D., Stora, T., Buehler, L., Miralbell, R., and Prior, J. 68Ga-labeled NODAGA- and DOTA-neurotensin analogs for targeting breast, prostate and pancreas cancers. Available online:http://www.radiologiekongress.ch/cms/website.php?id=/de/attendees/program.htm.
27. A TDPAC-camera10.1016/0168-9002(89)90311-2 ↗
28. Proposal to the ISOLDE committee CERN/ISC91-92/ISC/P20. Available online:https://cds.cern.ch/record/5746?ln=en.
29. 199mHg-derivatives of ascorbate oxidase and laccase: Selective depletion and blocking of Cu-sites10.1007/BF00567475 ↗
30. Hg-coordination studies of cysteine containing oligopeptides10.1515/zna-1996-5-617 ↗
31. Small scale intramolecular flexibility in 111mCd-plastocyanin10.1515/zna-1996-5-618 ↗
32. Hg-coordination studies of oligopeptides containing cysteine, histidine and tyrosine by 199mHg-TDPAC10.1023/A:1017008631060 ↗
33. Measurement and calculation of electric field gradients in Hg-mercaptides10.1515/zna-1998-6-721 ↗
34. The application of 199Hg NMR and 199m Perturbed Angular Correlation (PAC) Spectroscopy to define the biological chemistry of Hg(II): A case study with designed two- and three-stranded coiled coils10.1002/chem.200701208 ↗
35. Design of a three-helix bundle capable of binding heavy metals in a triscysteine environment10.1002/anie.201006413 ↗
36. Probing the coordination environment of the human copper chaperone HAH1: Characterization of Hg(II)-bridged homodimeric species in solution10.1002/chem.201204184 ↗
37. Gottberg, A., Stachura, M., Kowalska, M., Bissell, M.L., Arcisauskaite, V., Blaum, K., Helmke, A., Johnston, K., Kreim, K., and Larsen, F.H. (2014). Billion-fold sensitivity improvement in NMR spectroscopy of magnesium ions in solution. Angew. Chem., Unpublished work.